根治性前列腺切除术后复发前列腺癌的淋巴结失败模式及挽救治疗意义
本文为一项关键文献综述,聚焦根治性前列腺切除术后生化失败患者中PET-CT的应用证据,识别盆腔淋巴结复发部位并探讨其对挽救治疗的影响。综述指出最佳PET-CT示踪剂尚不确定,前列腺特异性膜抗原PET-CT应用增加使生化与影像复发界限模糊;挽救放疗最适靶区仍不明确,基于PET-CT的淋巴结复发映射提示扩大全盆腔放疗体积以覆盖更上淋巴结区域可能有益。
要点
- PSMA PET-CT在低PSA水平检测淋巴结转移的应用增加,使生化与影像复发阶段界限模糊。
- 挽救放疗最适靶区未定,PET-CT淋巴结复发映射提示扩大全盆腔体积或可覆盖更上淋巴结区。
- 现有试验探索术后全盆腔加前列腺窝放疗、PET-CT引导挽救放疗及转移导向治疗联合全盆腔放疗。
核心结论
- 挽救放疗最适靶区仍不确定,基于PET-CT映射淋巴结复发的研究提示扩大全盆腔放疗体积以增加对上位淋巴结区域覆盖可能具有作用。
研究设计与样本
- 本文为关键文献综述,检索并汇总根治性前列腺切除术后生化失败患者中PET-CT应用及盆腔淋巴结复发部位的相关证据。
主要发现
- 最佳PET-CT示踪剂尚不确定,但前列腺特异性膜抗原PET-CT在低前列腺特异性抗原水平探查淋巴结转移部位的应用增加,使生化复发与影像学复发阶段的界限模糊。
关键数值与推荐
- 最佳治疗策略尚未明确,当前试验正在研究术后全盆腔放疗联合前列腺窝放疗、生化复发时以PET-CT引导挽救放疗,以及仅淋巴结复发患者在全盆腔放疗基础上联合立体定向消融放疗等转移导向治疗。
临床怎么用
- 基于PET-CT映射的淋巴结复发部位,可考虑将全盆腔放疗体积扩大以覆盖更上位的淋巴结区域。
- 影像组学和放射基因组学等新兴领域可能提供预后信息并辅助复发前列腺癌患者的决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: There is increasing use of radical prostatectomy to treat patients with high-risk prostate cancer. This has contributed toward a pathologic stage migration, and a greater number of patients are subsequently being diagnosed with biochemical failure. There is increasing use of advanced imaging techniques in the setting of biochemical failure, including positron emission tomography-computed tomography (PET-CT). METHODS AND MATERIALS: This critical literature review highlights the evidence for PET-CT in postprostatectomy biochemical failure and identifies sites of pelvic lymph node relapse in the setting of biochemical failure and the potential implications that the locations of these relapses may have for salvage therapies. Potential future directions are then considered. RESULTS: The optimal PET-CT tracer remains uncertain but there is increasing use of prostate-specific membrane antigen PET-CT for investigating sites of nodal metastasis at low prostate-specific antigen levels, and this is leading to a blurring of the biochemical and radiologic recurrence phases. The optimal therapeutic approach remains undefined, with current trials investigating postoperative radiation therapy to the whole pelvis in addition to the prostatic fossa, the use of PET-CT in the setting of biochemical recurrence to guide delivery of salvage radiation therapy, and, for patients with node-only relapsed prostate cancer, the addition of whole pelvis radiation therapy to metastasis-directed therapies such as stereotactic ablative radiotherapy. CONCLUSIONS: The most appropriate target volume for salvage radiation therapy remains uncertain, and the findings of studies using PET-CT to map nodal recurrences suggest that there could be a role for extending whole pelvis radiation therapy volumes to increase coverage of superior nodal regions. The emerging fields of radiomics and radiogenomics could provide important prognostic information and aid decision making for patients with relapsed prostate cancer.
引用
- Slevin F, Beasley M, Cross W, et al. Patterns of Lymph Node Failure in Patients With Recurrent Prostate Cancer Postradical Prostatectomy and Implications for Salvage Therapies. Adv Radiat Oncol. 2020. PMID: 33305073. doi:10.1016/j.adro.2020.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。